| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9157 |
| Human Intestinal Absorption | HIA+ | 0.9635 |
| Caco-2 Permeability | Caco2+ | 0.6573 |
| P-glycoprotein Substrate | Non-substrate | 0.6713 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9089 |
| Non-inhibitor | 0.9441 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9068 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9375 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7835 |
| CYP450 2D6 Substrate | Non-substrate | 0.9341 |
| CYP450 3A4 Substrate | Non-substrate | 0.7682 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8313 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7552 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9364 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8775 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9632 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9072 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9743 |
| Non-inhibitor | 0.9736 |
| AMES Toxicity | Non AMES toxic | 0.9664 |
| Carcinogens | Non-carcinogens | 0.6573 |
| Fish Toxicity | High FHMT | 0.9123 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9822 |
| Honey Bee Toxicity | High HBT | 0.5907 |
| Biodegradation | Ready biodegradable | 0.9104 |
| Acute Oral Toxicity | III | 0.7854 |
| Carcinogenicity (Three-class) | Non-required | 0.7193 |